Dcf Advisers, LLC Zai Lab LTD Transaction History
Dcf Advisers, LLC
- $177 Million
- Q4 2024
A detailed history of Dcf Advisers, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Dcf Advisers, LLC holds 64,750 shares of ZLAB stock, worth $2.01 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
64,750
Previous 42,250
53.25%
Holding current value
$2.01 Million
Previous $1.02 Million
66.34%
% of portfolio
0.96%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$206 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$203 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$199 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$98.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$77.7 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.03B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...